Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Physicians (General practice) --- Primary care (Medicine) --- Patient-centered health care

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Older people --- Patient-centered health care --- Health insurance --- Medicare. --- Medical care --- Costs. --- Cost control.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Patient-centered health care --- Outcome assessment (Medical care) --- Trusts and trustees --- United States. --- Patient-Centered Outcomes Research Institute (U.S.)

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Patient-centered health care --- Medical informatics --- Medicine, Comparative --- Medical care --- Federal aid to medical care research --- Trusts and trustees --- Evaluation. --- Research --- Patient-Centered Outcomes Research Institute (U.S.) --- United States. --- Appropriations and expenditures.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Personalized healthcare-or what the award-winning author Donna Dickenson calls "Me Medicine"-is radically transforming our longstanding "one-size-fits-all" model. Technologies such as direct-to-consumer genetic testing, pharmacogenetically developed therapies in cancer care, private umbilical cord blood banking, and neurocognitive enhancement claim to cater to an individual's specific biological character, and, in some cases, these technologies have shown powerful potential. Yet in others they have produced negligible or even negative results. Whatever is behind the rise of Me Medicine, it isn't just science. So why is Me Medicine rapidly edging out We Medicine, and how has our commitment to our collective health suffered as a result? In her cogent, provocative analysis, Dickenson examines the economic and political factors fueling the Me Medicine phenomenon and explores how, over time, this paradigm shift in how we approach our health might damage our individual and collective well-being. Historically, the measures of "We Medicine," such as vaccination and investment in public-health infrastructure, have radically extended our life spans, and Dickenson argues we've lost sight of that truth in our enthusiasm for "Me Medicine." Dickenson explores how personalized medicine illustrates capitalism's protean capacity for creating new products and markets where none existed before-and how this, rather than scientific plausibility, goes a long way toward explaining private umbilical cord blood banks and retail genetics. Drawing on the latest findings from leading scientists, social scientists, and political analysts, she critically examines four possible hypotheses driving our Me Medicine moment: a growing sense of threat; a wave of patient narcissism; corporate interests driving new niche markets; and the dominance of personal choice as a cultural value. She concludes with insights from political theory that emphasize a conception of the commons and the steps we can take to restore its value to modern biotechnology.

Sociology of health --- Professional ethics. Deontology --- biotechnologie --- bio-ethiek (medische, biomedische ethiek, bio-ethische aspecten) --- Medicine, Preventive --- Patient-centered health care --- Biotechnology --- Precision Medicine --- Public Health Practice --- Social Justice. --- Common Good --- Justice --- Obligations of Society --- Good, Common --- Justice, Social --- Medical care --- Disease prevention --- Diseases --- Prevention of disease --- Preventive medicine --- Pathology --- Preventive health services --- Preventive medicine physicians --- Public health --- bioéthique (éthique médicale, biomédicale, aspects bioéthiques) --- Moral and ethical aspects. --- ethics. --- Prevention --- Individualized Medicine --- precisiegeneeskunde --- gepersonaliseerde gezondheidszorg --- médecine de précision --- soins de santé personnalisés --- Social Justice --- ethics